Pizzuti Dana
Officer at CRNX
- Sold, on record
- $7.1M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Dec 1, 2025
- Form 144 notices
- 18
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CRNXCrinetics Pharmaceuticals, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CRNXRoutineOct 1, 2025 2025
Sold 5,000 shares at $41.81 ($209k)
Pizzuti Dana, Chief Med and Dev Officer
10b5-1 planSold 7% of holdings ($3M position)66,270 shares left0.3x usual sizeFollows a Form 144Filing
- 2 Form 144 notice CRNXNoticeNov 3, 2025 +33 days
Filed to sell 5,000 shares ($218k)
Pizzuti Dana, Officer
10b5-1 plan0.4x usual sizeFiling
- 3 Form 4 sale CRNXRoutineNov 3, 2025 same day
Sold 5,000 shares at $42.66 ($213k)
Pizzuti Dana, Chief Med and Dev Officer
10b5-1 planSold 7% of holdings ($3M position)66,270 shares left0.4x usual sizeFollows a Form 144Filing
- 4 Form 144 notice CRNXNoticeDec 1, 2025 +28 days
Filed to sell 5,000 shares ($228k)
Pizzuti Dana, Officer
10b5-1 plan0.5x usual sizeFiling
- 5 Form 4 sale CRNXRoutineDec 1, 2025 same day
Sold 5,000 shares at $45.02 ($225k)
Pizzuti Dana, Chief Med and Dev Officer
10b5-1 planSold 7% of holdings ($3.2M position)66,837 shares left0.5x usual sizeFollows a Form 144Filing
- 6 Form 144 notice CRNXNoticeJan 2, 2026 +32 days
Filed to sell 5,000 shares ($233k)
Pizzuti Dana, Officer
10b5-1 plan0.5x usual sizeFiling
- 7 Form 144 notice CRNXNoticeFeb 2, 2026 +31 days
Filed to sell 10,000 shares ($499k)
Pizzuti Dana, Officer
10b5-1 plan1.3x usual sizeFiling
- 8 Form 144 notice CRNXNoticeMar 18, 2026 +44 days
Filed to sell 24,756 shares ($938k)
Pizzuti Dana, Officer
10b5-1 plan3.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (35)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Mar 18, 2026 | CRNX | Officer | Form 144 notice | 24,756 | $938k | Notice | SEC | |
| Feb 2, 2026 | Feb 2, 2026 | CRNX | Officer | Form 144 notice | 10,000 | $499k | Notice | SEC | |
| Jan 2, 2026 | Jan 2, 2026 | CRNX | Officer | Form 144 notice | 5,000 | $233k | Notice | SEC | |
| Dec 1, 2025 | Dec 3, 2025 | CRNX | Chief Med and Dev Officer | Form 4 sale | 5,000 | $225k | 7.0% | Routine | SEC |
| Dec 1, 2025 | Dec 1, 2025 | CRNX | Officer | Form 144 notice | 5,000 | $228k | Notice | SEC | |
| Nov 3, 2025 | Nov 5, 2025 | CRNX | Chief Med and Dev Officer | Form 4 sale | 5,000 | $213k | 7.0% | Routine | SEC |
| Nov 3, 2025 | Nov 3, 2025 | CRNX | Officer | Form 144 notice | 5,000 | $218k | Notice | SEC | |
| Oct 1, 2025 | Oct 3, 2025 | CRNX | Chief Med and Dev Officer | Form 4 sale | 5,000 | $209k | 7.0% | Routine | SEC |
| Oct 1, 2025 | Oct 1, 2025 | CRNX | Officer | Form 144 notice | 5,000 | $208k | Notice | SEC | |
| Sep 2, 2025 | Sep 4, 2025 | CRNX | Chief Med and Dev Officer | Form 4 sale | 5,000 | $161k | 4.9% | Routine | SEC |
| Sep 2, 2025 | Sep 2, 2025 | CRNX | Officer | Form 144 notice | 5,000 | $155k | Notice | SEC | |
| Aug 22, 2025 | Aug 26, 2025 | CRNX | Chief Med and Dev Officer | Form 4 sale | 30,000 | $913k | 31.2% | Routine | SEC |
| Aug 22, 2025 | Aug 22, 2025 | CRNX | Officer | Form 144 notice | 30,000 | $882k | Notice | SEC | |
| Aug 20, 2025 | Aug 21, 2025 | CRNX | Chief Med and Dev Officer | Form 4 sale | 6,492 | $189k | 8.9% | Routine | SEC |
| Aug 20, 2025 | Aug 20, 2025 | CRNX | Officer | Form 144 notice | 6,492 | $191k | Notice | SEC | |
| Mar 19, 2025 | Mar 21, 2025 | CRNX | Chief Med and Dev Officer | Form 4 sale | 2,515 | $86k | 3.4% | Routine | SEC |
| Feb 3, 2025 | Feb 5, 2025 | CRNX | Chief Med and Dev Officer | Form 4 sale | 5,000 | $195k | 13.6% | Routine | SEC |
| Feb 3, 2025 | Feb 3, 2025 | CRNX | Officer | Form 144 notice | 5,000 | $195k | Notice | SEC | |
| Jan 3, 2025 | Jan 7, 2025 | CRNX | Chief Med and Dev Officer | Form 4 sale | 15,000 | $781k | 33.9% | Routine | SEC |
| Jan 3, 2025 | Jan 3, 2025 | CRNX | Officer | Form 144 notice | 15,000 | $781k | Notice | SEC | |
| Oct 3, 2024 | Oct 7, 2024 | CRNX | Chief Med and Dev Officer | Form 4 sale | 14,375 | $785k | 33.5% | Routine | SEC |
| Oct 3, 2024 | Oct 3, 2024 | CRNX | Officer | Form 144 notice | 14,375 | $785k | Notice | SEC | |
| Jul 3, 2024 | Jul 5, 2024 | CRNX | Chief Med and Dev Officer | Form 4 sale | 14,375 | $645k | 33.5% | Routine | SEC |
| Jul 3, 2024 | Jul 3, 2024 | CRNX | Officer | Form 144 notice | 14,375 | $645k | Notice | SEC | |
| Jun 24, 2024 | Jun 25, 2024 | CRNX | Chief Med and Dev Officer | Form 4 sale | 9,500 | $434k | 25.5% | Unusual | SEC |
| Jun 24, 2024 | Jun 24, 2024 | CRNX | Officer | Form 144 notice | 9,500 | $434k | Notice | SEC | |
| Apr 15, 2024 | Apr 17, 2024 | CRNX | Chief Med and Dev Officer | Form 4 sale | 14,375 | $639k | 34.1% | Routine | SEC |
| Apr 15, 2024 | Apr 15, 2024 | CRNX | Officer | Form 144 notice | 14,375 | $639k | Notice | SEC | |
| Mar 20, 2024 | Mar 22, 2024 | CRNX | Chief Med and Dev Officer | Form 4 sale | 15,089 | $665k | 35.2% | Unusual | SEC |
| Mar 20, 2024 | Mar 20, 2024 | CRNX | Officer | Form 144 notice | 15,089 | $665k | Notice | SEC | |
| Jan 3, 2024 | Jan 4, 2024 | CRNX | Chief Med and Dev Officer | Form 4 sale | 14,375 | $503k | 70.9% | Routine | SEC |
| Jan 3, 2024 | Jan 3, 2024 | CRNX | Officer | Form 144 notice | 14,375 | $503k | Notice | SEC | |
| Dec 21, 2023 | Dec 22, 2023 | CRNX | Chief Med and Dev Officer | Form 4 sale | 9,583 | $331k | 61.8% | Unusual | SEC |
| Dec 21, 2023 | Dec 21, 2023 | CRNX | Officer | Form 144 notice | 9,583 | $331k | Notice | SEC | |
| Apr 5, 2023 | Apr 5, 2023 | CRNX | Chief Development Officer | Form 4 sale | 8,212 | $133k | 64.6% | Routine | SEC |